Goldman Sachs Group upgraded shares of HCA Healthcare (NYSE:HCA) from a neutral rating to a buy rating in a report issued on Wednesday, 24/7 WallStreet reports. They currently have $160.00 price target on the stock, up from their previous price target of $147.00.
Several other brokerages have also recently issued reports on HCA. Raymond James set a $86.00 price target on shares of Gilead Sciences and gave the company a buy rating in a research report on Tuesday, April 23rd. UBS Group reiterated a sell rating on shares of in a research report on Monday, June 24th. Deutsche Bank cut shares of Hilton Hotels from a buy rating to a hold rating and set a $92.60 price objective on the stock. in a report on Wednesday, May 1st. They noted that the move was a valuation call. Jefferies Financial Group set a $158.00 price objective on shares of HCA Healthcare and gave the stock a buy rating in a report on Wednesday, April 17th. Finally, Zacks Investment Research upgraded shares of GALP ENERGIA SG/ADR from a sell rating to a hold rating in a report on Monday, May 27th. Two analysts have rated the stock with a sell rating, three have given a hold rating and nineteen have given a buy rating to the company’s stock. The stock has an average rating of Buy and a consensus price target of $149.87.
Shares of NYSE HCA opened at $141.51 on Wednesday. HCA Healthcare has a 1 year low of $105.28 and a 1 year high of $147.42. The company’s 50-day moving average is $129.96. The stock has a market capitalization of $47.46 billion, a PE ratio of 14.48, a P/E/G ratio of 1.11 and a beta of 0.80.
The company also recently announced a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Monday, June 3rd were paid a $0.40 dividend. The ex-dividend date of this dividend was Friday, May 31st. This represents a $1.60 annualized dividend and a dividend yield of 1.13%. HCA Healthcare’s dividend payout ratio is presently 16.38%.
In other news, insider Jon M. Foster sold 44,281 shares of the company’s stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $122.28, for a total value of $5,414,680.68. Following the transaction, the insider now owns 96,052 shares in the company, valued at $11,745,238.56. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 2.70% of the company’s stock.
Institutional investors have recently modified their holdings of the stock. LPL Financial LLC grew its stake in shares of HCA Healthcare by 6.7% during the fourth quarter. LPL Financial LLC now owns 10,404 shares of the company’s stock worth $1,295,000 after purchasing an additional 651 shares during the period. Raymond James & Associates grew its stake in shares of HCA Healthcare by 2.3% during the fourth quarter. Raymond James & Associates now owns 59,743 shares of the company’s stock worth $7,435,000 after purchasing an additional 1,371 shares during the period. Commonwealth Equity Services LLC grew its stake in shares of HCA Healthcare by 8.7% during the fourth quarter. Commonwealth Equity Services LLC now owns 7,639 shares of the company’s stock worth $950,000 after purchasing an additional 610 shares during the period. Advisor Group Inc. grew its stake in shares of HCA Healthcare by 30.2% during the fourth quarter. Advisor Group Inc. now owns 10,296 shares of the company’s stock worth $1,282,000 after purchasing an additional 2,389 shares during the period. Finally, Commonwealth Bank of Australia grew its stake in shares of HCA Healthcare by 4.6% during the fourth quarter. Commonwealth Bank of Australia now owns 2,783 shares of the company’s stock worth $344,000 after purchasing an additional 122 shares during the period. Institutional investors own 70.23% of the company’s stock.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Recommended Story: Return on Investment (ROI)
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.